PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,000 | 0.0% | 260 | +23.8% | 0.00% | 0.0% |
| Q3 2019 | $6,000 | +50.0% | 210 | +40.0% | 0.00% | +50.0% |
| Q2 2019 | $4,000 | +33.3% | 150 | +50.0% | 0.00% | 0.0% |
| Q1 2019 | $3,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | 0.0% | 100 | -16.7% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | -40.0% | 120 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $5,000 | +25.0% | 120 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $4,000 | -33.3% | 120 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $6,000 | -99.9% | 120 | -36.8% | 0.00% | -50.0% |
| Q3 2017 | $10,266,000 | -3.8% | 190 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $10,672,000 | +47.4% | 190 | 0.0% | 0.01% | +40.0% |
| Q1 2017 | $7,239,000 | +144680.0% | 190 | 0.0% | 0.01% | +66.7% |
| Q4 2016 | $5,000 | 0.0% | 190 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | +150.0% | 190 | +111.1% | 0.00% | +200.0% |
| Q1 2016 | $2,000 | – | 90 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,220,672 | $52,025,000 | 8.00% |
| Fernwood Investment Management, LLC | 190,011 | $8,098,000 | 7.10% |
| Cormorant Asset Management, LP | 500,000 | $21,310,000 | 3.40% |
| HARVEY CAPITAL MANAGEMENT INC | 157,930 | $6,730,000 | 2.69% |
| Atika Capital Management LLC | 128,000 | $5,456,000 | 2.68% |
| Redmile Group, LLC | 769,641 | $32,802,000 | 2.48% |
| Temasek Holdings (Private) Ltd | 5,833,568 | $248,627,000 | 2.36% |
| SECTORAL ASSET MANAGEMENT INC | 1,088,118 | $46,376,000 | 2.12% |
| Eventide Asset Management | 479,900 | $20,453,000 | 1.19% |
| BBT Capital Management, LLC | 200,000 | $8,524,000 | 0.79% |